Meningeal immunity and its function in maintenance of the central nervous system in health and disease
10.1146/annurev-immunol-102319-103410 · doi-reference
Bacteria hijack a meningeal neuroimmune axis to facilitate brain invasion
10.1038/s41586-023-05753-x · doi-reference
Microglia replacement halts the progression of microgliopathy in mice and humans
10.1126/science.adr1015 · doi-reference
The impact of CSF1R inhibitor-mediated microglial depletion in rodent models of Alzheimer’s and Parkinson’s disease: a systematic review and meta-analysis
10.3389/fnagi.2026.1733682 · doi-reference
Microglia depletion reduces neurodegeneration and remodels extracellular matrix in a mouse Parkinson’s disease model triggered by α-synuclein overexpression
10.1038/s41531-024-00846-4 · doi-reference
Microglia depletion reduces human neuronal APOE4-related pathologies in a chimeric Alzheimer’s disease model
10.1016/j.stem.2024.10.005 · doi-reference
Exploring microglial replacement: from disease models to clinical translation
10.1016/j.bbi.2025.06.011 · doi-reference
Microglial depletion, a new tool in neuroinflammatory disorders: comparison of pharmacological inhibitors of the CSF‐1R
10.1002/glia.24664 · doi-reference
Validation of induced microglia-like cells (iMG cells) for future studies of brain diseases
10.3389/fncel.2021.629279 · doi-reference
Introducing directly induced microglia-like (iMG) cells from fresh human monocytes: a novel translational research tool for psychiatric disorders
10.3389/fncel.2015.00184 · doi-reference
Direct induction of microglia-like cells from human monocytes: a novel cellular tool for translational research of neuropsychiatric disorders
10.1093/ijnp/pyae059.149 · doi-reference
Proteomic biomarkers of Kleine–Levin syndrome
10.1093/sleep/zsac097 · doi-reference
Altered eotaxin-1 and interleukin-34 levels in obsessive-compulsive disorder: a case-control observational study in Bangladesh
10.24171/j.phrp.2024.0222 · doi-reference
PET imaging unveils neuroinflammatory mechanisms in psychiatric disorders: from microglial activation to therapeutic innovation
10.1007/s12035-025-05177-w · doi-reference
Neuroinflammation in schizophrenia: an overview of evidence and implications for pathophysiology
10.31083/jin27636 · doi-reference
Editorial of special issue "Latest multifactorial developments on neuropsychiatric disorders and manifestations"
10.3390/cimb47030183 · doi-reference
An update on Kleine–Levin syndrome
10.1007/s40675-022-00246-1 · doi-reference
From Alzheimer’s disease to anxiety, epilepsy to schizophrenia: a comprehensive dive into neuro-psychiatric disorders
10.7759/cureus.58776 · doi-reference
Patients with severe multiple sclerosis exhibit functionally altered CD8+ regulatory T cells
10.1212/nxi.0000000000200016 · doi-reference
Neuron-specific vitamin D signaling attenuates microglia activation and CNS autoimmunity
10.3389/fneur.2020.00019 · doi-reference
Is there a relationship between CSF interleukin 34 level and clinicoradiological activity and IgG index in patients with MS
10.1016/j.msard.2024.106150 · doi-reference
Profiling of microglia nodules in multiple sclerosis reveals propensity for lesion formation
10.1038/s41467-024-46068-3 · doi-reference
Roles and regulation of microglia activity in multiple sclerosis: insights from animal models
10.1038/s41583-023-00709-6 · doi-reference
Targeting mitochondrial Kv1. 3 enables precise autoreactive T cell therapy for multiple sclerosis
10.1016/b978-0-12-398270-4.00030-6 · doi-reference
Role for cFMS in maintaining alternative macrophage polarization in SIV infection: implications for HIV neuropathogenesis
10.1186/s12974-015-0272-1 · doi-reference
Role of the pro‐inflammatory cytokines TNF‐α and IL‐1β in HIV‐associated dementia
10.1111/j.1365-2362.2006.01657.x · doi-reference
CNS inflammation and macrophage/microglial biology associated with HIV-1 infection
10.1007/s11481-009-9174-2 · doi-reference
Microglial cells: the main HIV-1 reservoir in the brain
10.3389/fcimb.2019.00362 · doi-reference
Cognitive neuropsychology of HIV-associated neurocognitive disorders
10.1007/s11065-009-9102-5 · doi-reference
HIV-associated neurocognitive disorder
10.1097/qco.0000000000000328 · doi-reference
IL-34 induces the differentiation of human monocytes into immunosuppressive macrophages. antagonistic effects of GM-CSF and IFNγ
10.1371/journal.pone.0056045 · doi-reference
Correlation between cystatin-C and interleukin-34 expression detection and post-stroke cognitive impairment
10.29271/jcpsp.2025.08.1065 · doi-reference
Increased serum interleukin-34 levels as a novel diagnostic and prognostic biomarker in patients with acute ischemic stroke
10.1016/j.jneuroim.2021.577652 · doi-reference
Role of inflammation and its mediators in acute ischemic stroke
10.1007/s12265-013-9508-6 · doi-reference
Inflammatory mechanisms in ischemic stroke: therapeutic approaches
10.1186/1479-5876-7-97 · doi-reference
Structural analysis of ischemic stroke thrombi: histological indications for therapy resistance
10.3324/haematol.2019.219881 · doi-reference
Ischemic stroke: what does the histological composition tell us about the origin of the thrombus
10.1161/strokeaha.117.016590 · doi-reference
Ischemic stroke
10.1016/j.amjmed.2021.07.027 · doi-reference
Enhanced M-CSF/CSF1R signaling closely associates with PrPSc accumulation in the scrapie-infected cell line and the brains of scrapie-infected experimental rodents
10.1007/s12035-022-02989-y · doi-reference
Ferroptosis promotes T-cell activation-induced neurodegeneration in multiple sclerosis
10.1038/s41423-022-00883-0 · doi-reference
